Regenerative medicine and CAR-T therapy developments highlighted in Italy

Medical advancements in regenerative medicine and CAR-T cell therapies were the focus of recent scientific gatherings in Italy.

In Calabria, a conference at Palazzo Alvaro reviewed six years of CAR-T therapy implementation. Dr. Massimo Martino, Director at the Grande Ospedale Metropolitano (GOM) in Reggio Calabria, emphasized the role of these advanced cellular therapies in reducing healthcare migration. He noted that providing these specialized treatments locally helps patients remain in their home region for care while advancing oncological and hematological progress.

In Milan, the XI National Congress of the Italian Society of Multidisciplinary Regenerative Medicine and Surgery (S.I.M.C.R.I.) addressed the evolution of regenerative medicine. The event highlighted the synergy between academic research, clinical practice, and industrial innovation, specifically focusing on stem cells, biotechnology, and tissue engineering to improve biological repair processes.